Log in

GlaxoSmithKline Pharmaceuticals

GLAXO· NSE· Healthcare
₹2,655.60
−₹72.10 (−2.64%) · 1Das of 12 Nov 2026, 21:13 IST

GlaxoSmithKline Pharmaceuticals (GLAXO) last traded at ₹2,655.60 on NSE as of 12 Nov 2026, 21:13 IST, down 2.64% (−₹72.10) on the day. The stock is 14.9% below its 52-week high of ₹3,120.70 and 27.2% above its 52-week low of ₹2,088.10. Market cap ₹44,987 crore, trailing P/E 43.4×, P/B 19.7×, EPS ₹54.52. Sector: Healthcare.

Day range₹2,652.10 – ₹2,727.90
52-week range₹2,088.10 – ₹3,120.70
Volume64,4910.64× the 20-day average
Market cap₹44,987 crore
P/E · P/B43.4× · 19.7×trailing
EPS₹54.52
Returns1W+6.22%1M+4.90%3M+1.35%6M+11.21%YTD+10.09%1Y+8.64%3Y+83.78%5Y+68.90%

Fundamentals

Revenue growth· latest year+1.93%
Net margin27.1%
ROE / ROA— / 24.0%
Debt-to-equity0.0×
P/E · P/B· trailing43.4× · 19.7×
EPS₹54.52
Revenue / net income₹3,822 crore / ₹1,036 crore
Last reported year ends 31 Mar 2026

Technicals

RSI (14)55.5
20-day average· 4.9% above₹2,530.52
50-day average· 1.3% below₹2,689.87
200-day average· 6.3% above₹2,498.53
ATR (14)· 3.10% of price₹82.24
20-session change+4.58%
Volatility· 30 sessions, annualised32.3%
From completed sessions; the RSI alone steps with the live price.

Sector today

Healthcare
Move today+0.03%
Breadth53% of stocks up
RotationImproving
Against the NIFTY 50 · breadth is the share of the sector's stocks up today

Latest news

All GLAXO news ↗
  1. Buy GlaxoSmithKline Pharmaceuticals; target of Rs 2900: ICICI Securities
    Moneycontrol ↗ · 7 Nov 2026, 16:03 IST · Positive

Upcoming events

Event calendar ↗

No upcoming company event is listed for GlaxoSmithKline Pharmaceuticals.

Frequently asked

What is the GlaxoSmithKline Pharmaceuticals share price today?

GlaxoSmithKline Pharmaceuticals (GLAXO) last traded at ₹2,655.60 on NSE as of 12 Nov 2026, 21:13 IST, down 2.64% (−₹72.10) on the day.

What is the 52-week high and low of GLAXO?

The 52-week range of GlaxoSmithKline Pharmaceuticals is ₹2,088.10 to ₹3,120.70; the last price is 14.9% below the high.

What is the market capitalisation of GlaxoSmithKline Pharmaceuticals?

₹44,987 crore at the last price (NSE's issued shares × price).

What is the P/E ratio of GlaxoSmithKline Pharmaceuticals?

Trailing P/E 43.4× on EPS ₹54.52, from the annual statement for the year ended 31 Mar 2026.

Which sector is GlaxoSmithKline Pharmaceuticals in, and how is the sector doing today?

Healthcare. The sector is up 0.03% today, with 53% of its stocks up (Improving against the NIFTY 50).

What is the next scheduled event for GlaxoSmithKline Pharmaceuticals?

No upcoming company event is listed for GlaxoSmithKline Pharmaceuticals.

Data as of 12 Nov 2026, 21:13 IST · Research, not investment advice.